Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy

BACKGROUND: Hypoglycemia poses a significant clinical and economic burden to patients with type 2 diabetes mellitus (T2DM). Minimizing the risk of hypoglycemia is an important component when managing patients with T2DM. Understanding hypoglycemia rates and the associated economic consequences can he...

Descripción completa

Detalles Bibliográficos
Autores principales: Raju, Aditya, Shetty, Sharash, Cai, Beilei, D’Souza, Anna O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398174/
https://www.ncbi.nlm.nih.gov/pubmed/27123911
http://dx.doi.org/10.18553/jmcp.2016.22.5.483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398174/
https://www.ncbi.nlm.nih.gov/pubmed/27123911
http://dx.doi.org/10.18553/jmcp.2016.22.5.483

Ejemplares similares